non-functioning endocrine disease
Conditions
Interventions
The glasses that selectively reduce short-wavelength light with a similar absorbance sensitivity to ipRGCs (referred to as "
reducing glasses"
) and glasses that have minimal reduction effects but are difficult to distinguish from the reducing glasses based on appearance (referred to as "
non-reducing glasses"
) will be transferred to our university in a randomly packaged state by Mitsui Chemicals. Upon admission, the principal investigator or collaborator will distribute one of the packaged glasses to e
Sponsors
Hyogo Medical University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Participants who meet all of the following criteria will be included in the study: 1. Patients who have risk factors of atherosclerosis. 2. Individuals who have received sufficient explanations about participation in the study, have a thorough understanding, and have provided written consent voluntarily. 3. Excluding those deemed inappropriate as research subjects by the principal investigator, and all other criteria have been met.
Exclusion criteria
Exclusion criteria: Individuals who do not meet the eligibility criteria.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Melatonin, 6-sulphatoxymelatonin, and physical activity and autonomic nervous function during sleeping time | — |
Secondary
| Measure | Time frame |
|---|---|
| d-ROM, urine cortisol | — |
Countries
Japan
Contacts
Public ContactAkinori Kanzaki
Hyogo Medical University Diabetes, Endocrinology, and Clinical immunology
Outcome results
None listed